These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33902623)

  • 21. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
    Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.
    Medina-Marino A; Bezuidenhout D; Ngwepe P; Bezuidenhout C; Facente SN; Mabandla S; Hosek S; Little F; Celum CL; Bekker LG
    J Int AIDS Soc; 2022 Jul; 25(7):e25968. PubMed ID: 35872602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV risk, risk perception, and PrEP interest among adolescent girls and young women in Lilongwe, Malawi: operationalizing the PrEP cascade.
    Hill LM; Maseko B; Chagomerana M; Hosseinipour MC; Bekker LG; Pettifor A; Rosenberg NE
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25502. PubMed ID: 32602649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Buzibye A; Omali D; Chinyenze K; Kuteesa M; Kaleebu P; Price MA
    J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study.
    Mayanja Y; Kayesu I; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Price M; Kosidou K; Ekström AM
    Front Public Health; 2024; 12():1369256. PubMed ID: 38846614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative characterizations of relationships among South African adolescent girls and young women and male partners: implications for engagement across HIV self-testing and pre-exposure prophylaxis prevention cascades.
    Holmes LE; Kaufman MR; Casella A; Mudavanhu M; Mutunga L; Polzer T; Bassett J; Van Rie A; Schwartz S
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25521. PubMed ID: 32603025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creating allies: qualitative exploration of young women's preferences for PrEP methods and parents' role in PrEP uptake and user support in urban and rural Zambia.
    Wong CM; Munthali T; Mangunje FG; Katoka ML; Burke HM; Musonda B; Musonda M; Todd CS
    BMC Womens Health; 2024 Jan; 24(1):71. PubMed ID: 38273282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
    Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
    Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial.
    Munthali RJ; Stangl AL; Baron D; Barré I; Harvey S; Ramskin L; Colombini M; Naicker N; Kapiga S; Delany-Moretlwe S;
    AIDS Behav; 2022 Dec; 26(12):3950-3962. PubMed ID: 35776254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing for two: How enhancing human-centered design with behavioral nudges unlocked breakthroughs to promote young women's psychological safety and access to reproductive care in Tanzania.
    Liu JX; Vallin J; Chiu C; Cabrera FA; Hunter LA; Rao A; Njau P; McCoy SI
    Soc Sci Med; 2023 Mar; 320():115683. PubMed ID: 36709692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda.
    Lunkuse JF; Kamacooko O; Muturi-Kioi V; Chinyenze K; Kuteesa MO; Price MA; Mayanja Y
    BMC Infect Dis; 2022 May; 22(1):467. PubMed ID: 35578163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E; Sikkema KJ; Julies RF; Mazer K; O'Malley G; Heffron R; Morton JF; Johnson R; Celum C; Baeten JM; Bekker LG
    J Int AIDS Soc; 2024 May; 27(5):e26254. PubMed ID: 38695101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "They have this not care - don't care attitude:" A Mixed Methods Study Evaluating Community Readiness for Oral PrEP in Adolescent Girls and Young Women in a Rural Area of South Africa.
    Nakasone SE; Chimbindi N; Mthiyane N; Nkosi B; Zuma T; Baisley K; Dreyer J; Pillay D; Floyd S; Birdthistle I; Seeley J; Shahmanesh M
    AIDS Res Ther; 2020 Sep; 17(1):55. PubMed ID: 32894138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
    Irungu E; Khoza N; Velloza J
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
    J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa.
    Bergh K; Toska E; Duby Z; Govindasamy D; Mathews C; Reddy T; Jonas K
    AIDS Behav; 2024 Apr; 28(4):1137-1151. PubMed ID: 37462890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supporting young women's health through girl-friendly drug vendors in Lake Zone, Tanzania: protocol for the AmbassADDOrs for Health cluster-randomised controlled trial.
    Mnyippembe A; Sheira LA; McCoy SI; Njau PF; Packel LJ; Hassan K; Solorzano-Barrera C; Maokola W; Kang Dufour MS; Sabasaba A; Liu J
    BMJ Open; 2024 Jun; 14(6):e078755. PubMed ID: 38851225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.